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Introduction 
 Primary mucinous carcinoma of the 
skin (PMCS) is a rare, slow growing tumor 
with a high recurrence rate and occasional 
metastasis. It most commonly presents as an 
asymptomatic nodule on the face, 
particularly the eyelids.1 PMCS is resistant 
to radiation and chemotherapy. Historically, 
a wide local excision has been the treatment 
of choice, but it has high recurrence rates. 
While no current definitive treatment 
guidelines are available, limited data 
suggests that Mohs micrographic surgery 
(MMS) may result in significantly lower 
recurrence rates than excision.2 We report a 
case of recurrent PMCS treated with MMS. 
Case Report 
 A 48-year-old African American 
male presented with a two-year history of a 
subcutaneous, asymptomatic growth below 
his right eye. On clinical exam, a 3x2x1 cm 
non-tender, mobile, subcutaneous nodule 
was noted on the right lower eyelid and the 
zygomatic arch. He underwent excisional 
biopsy by plastic surgery two months later. 
Pathology showed an island of CK7 positive 
and CK 20 negative basaloid cells in the 
mucinous stroma consistent with primary 
mucinous carcinoma (figures 1, 2 & 3). The 
tumor was approaching the surgical margins. 
The patient was lost to follow up and 
presented fifteen months later with a 
recurrent growth in the right infraorbital 
area. 
 CT imaging showed a soft tissue 
mass without bony involvement. An MRI of 
the orbits, face and neck showed a 3.8x7x1.1 
cm right lower eyelid lesion with no bony 
involvement, as well as prominent bilateral 
neck lymph nodes and a thyroid mass. Chest 
X-ray and metastatic workup were 
unremarkable. A fine needle aspiration of 
the thyroid mass and cervical lymph node 
biopsy were both negative for metastasis. 
After a tumor board discussion MMS was 
recommended for complete resection of the 
tumor with adjuvant radiation therapy. 
 MMS was performed in 2 stages in an 
attempt to clear the deep margins (first stage 
shown in figure 4). The second stage showed 
clear margins without any residual tumor (the 
final MMS defect shown in figure 5). The orbital 
septum was violated medially. The patient 
underwent reconstruction by plastic surgery two 
_________________ 
From the Loma Linda University School of 
Medicine (C.J.) and the Loma Linda 
University Department of Dermatology 
(V.A., A.T.) 
Accepted for Publication: *** 
The authors have no funding, financial 
relationships, or conflicts of interest to 
disclose. 
Please address correspondence to: 
cjohnson@llu.edu 
 
   
Figure 1. H&E stain at 10x showing islands of 
basaloid cells surrounded by mucinous stroma;  
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days later with right cheek fasciculocutaneous 
flaps, right inferior orbicularis oculi muscle flap, 
medial canthopexy and lateral canthoplasty. In 
addition, the patient received 24 radiation 
treatments as per radiation oncology 
recommendations to prevent recurrence. Eight 
month follow up showed no recurrence. 
Discussion 
PMCS is a rare adnexal neoplasm of 
the mucinous sweat gland, which is often 
mistaken for metastasis from extracutaneous 
sites, such as gastrointestinal tract or breast. 
Clinical presentation may vary, with the 
classic presentation of nontender, well-
circumscribed nodules of varying color.1 
The most common location of the neoplasm 
is the eyelid and eyebrow (49.7%), followed 
by non-periorbital face & neck (19.5%) and 
scalp (17%).1 Thorough physical 
examination must be performed with a focus 
on lymph node and breast exam to exclude 
metastasis and extracutanous origins, 
respectively. 
 The origin of PMCS is controversial. 
It was historically thought to be a variant of 
eccrine differentiation, but is now 
considered a tumor of apocrine 
differentiation.2 Histology shows dermal 
avascular, irregular clusters of basaloid cells 
with rare mitosis surrounded by abundant 
mucin.3 There are three types of PMCS: 
pure, mixed, and mucocele.6 Pure types 
originate as in-situ and lack an invasive 
ductal component. As mucin builds up and 
distends the duct, it displaces the 
myoepithelial layer resulting in a classic 
histopathology of epithelioid nests in a pool 
of mucin without an identifiable in-situ 
component. Mixed type is similar to the 
pure, but with an invasive ductal component. 
Mucocele type displays configurations 
which are diastase and hyaluronidase 
resistant and can mimic a benign breast 
mucocele as well as a ductal breast 
adenocarcinoma.4 
 Workup for suspected PMCS 
includes colonoscopy, barium enema and 
mammography, to evaluate for 
extracutaneous origin. CT imaging may be 
necessary to exclude metastases.2 Unlike 
PMCS, cutaneous metastases from 
mammary adenocarcinoma exhibit a 
predilection for the chest and axilla rather 
than the face.2 Treatment has conventionally 
been wide local excision, but there is a high 
rate of recurrence, ranging from 34-36%.5 
Metastases of the primary lesion are less 
common, occurring in about 14% of cases.6 
PMCS is resistant to chemotherapy and 
radiation.  
 In a review of the literature, there are 
a few case reports demonstrating the success 
of MMS. A small case series of 6 patients 
with mucinous carcinoma treated with MMS 
showed no recurrence. The 20 to 36 month 
follow up indicated that long-term 
recurrence rates were lower (13%) then 
  
Figure 2. Deep dermal component at 2x magnification; Figure 3. CK7 positive tumor cells at 
20x 
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recurrences after a wide local excision 
(34%).7 
 In a meta-analysis of PMCS cases 
reported between 1952 and 2010, a total of 
59 cases were found. Caucasian race, 
advanced age, and male gender were 
demonstrated as the most likely risk factors. 
One hundred and thirty six of the patients in 
the meta-analysis were treated with wide 
local excision with 1 cm margins and 15 
were treated with Mohs surgery. Of those 
treated with Mohs, 2 (13%) had recurrence 
with no reported metastases. In comparison, 
those with wide local excision, 46 (34%) 
had recurrence or metastases. Overall 
recurrence was 19.6%.2 
Although there are no current official guidelines 
for treatment of PMCS, the data indicates that 
MMS may be a superior treatment with lower 
recurrence rates compared to wide local 
excision. While additional studies are needed, 
our experience thus far supports favorable 
outcomes with the use of MMS in treatment of 
PMCS. 
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Figure 4. First stage of MMS ; Figure 5. Second stage, final defect of MMS 
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